Chlorofluoromethane (CH2ClF) is a synthetic organic compound that was once widely used as a refrigerant, propellant, and solvent. It is a colorless gas with a slightly sweet odor. Chlorofluoromethane is synthesized through the reaction of methane with chlorine and fluorine. It was extensively studied in the past due to its role in ozone depletion, a major environmental concern. The compound's high stability and ability to persist in the atmosphere allowed it to reach the stratosphere, where it decomposed under UV radiation, releasing chlorine atoms that catalytically destroyed ozone molecules. This led to a global ban on the production and use of chlorofluorocarbons, including chlorofluoromethane, under the Montreal Protocol. The research on chlorofluoromethane and its effects on the ozone layer has played a crucial role in understanding atmospheric chemistry and the importance of protecting the ozone layer.'
| ID Source | ID |
|---|---|
| PubMed CID | 11643 |
| CHEBI ID | 82418 |
| MeSH ID | M0117767 |
| Synonym |
|---|
| cum8ouo53e , |
| unii-cum8ouo53e |
| 1691-88-9 |
| methane, chlorofluoro- |
| chlorofluoromethane |
| 593-70-4 |
| chloro(fluoro)methane |
| monochloromonofluoromethane |
| khladon 31 |
| g 31 |
| r 31 (refrigerant) |
| einecs 209-803-2 |
| hcfc-31 |
| ccris 136 |
| genetron 31 |
| methylene chloride fluoride |
| cfc 31 |
| brn 1730796 |
| fc 31 |
| freon 31 |
| FT-0693133 |
| chloranyl(fluoranyl)methane |
| A832286 |
| C19362 |
| AKOS006229037 |
| 220437-77-4 |
| carbon chloride fluoride |
| fluorochloromethane |
| chlorofluoromethane [iarc] |
| CHEBI:82418 |
| hcfc 31 |
| ch2fcl |
| ch2clf |
| mfcd00040114 |
| DTXSID6020305 |
| Q421766 |
| DTXSID10424071 |
| Class | Description |
|---|---|
| hydrochlorofluorocarbon | An organochlorine compound derived from methane, ethane or propane that contains atoms of hydrogen, chlorine, fluorine, and carbon only. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (51.00) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||